Nanoparticles: Properties and Potential Applications in Tumor Diagnosis and Therapy
A special issue of Nanomaterials (ISSN 2079-4991). This special issue belongs to the section "Biology and Medicines".
Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 7334
Special Issue Editors
Interests: nanomedicine; tumor mechanics; tumor treatment; cancer diagnosis, CRISPR/Cas delivery
Special Issue Information
Dear Colleagues,
Cancer is one of the leading causes of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. Traditional cancer therapies include chemotherapy, radiation therapy, and immunotherapy. Compared to the limitation of traditional therapies, such as lack of specificity, cytotoxicity, and multi-drug resistance, nanomedicine has multiple advantages for cancer diagnosis and treatment. Nanoparticles can be used as cancer therapeutics and diagnosis reagents to treat cancer due to their advantages of reduced toxicity, biocompatibility, better stability, enhanced permeability and retention effect, and precise targeting. Various nanotherapeutics have been developed and investigated for cancer treatment. However, approved nanomedicines for cancer treatment and diagnosis have not increased by much over the years.
This Special Issue will present comprehensive research outlining progress on the application of nanoparticles to improve the efficacy of cancer diagnosis and therapy. This includes improvements in nanoparticle performance through functionalized nanoparticles, optimized nanoparticle size, surface chemistry, cellular targeting, etc. We invite authors to contribute original research articles and review articles covering the current progress on nanoparticle properties and potential applications in tumor diagnosis and therapy. Potential topics include but are not limited to:
- Synthesis of novel nanoparticles.
- Fabrication of nanoparticles for improving tumor therapy or diagnosis.
- Optimization of lipid nanoparticles for delivery of small molecules or macromolecules including nucleic acids.
- Improvement in tumor therapy efficacy based on nanoparticles.
- Combined cancer therapy based on nanoparticles.
Dr. Di Zhang
Guest Editor
Dr. Zeru Tian
Assistant Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- magnetic nanoparticles
- lipid nanoparticles
- gold nanoparticles
- polymeric nanoparticles
- tumor dignotherapy
